nipah
viru
niv
togeth
hendra
viru
hev
close
relat
highli
pathogen
zoonos
type
speci
within
paramyxoviru
genu
henipaviru
virus
caus
signific
morbid
mortal
varieti
vertebr
speci
includ
human
henipavirus
categor
zoonot
biosafeti
level
agent
limit
extens
examin
vivo
pathogen
featur
develop
evalu
therapeut
vaccin
niv
hev
select
agent
biodefens
concern
classifi
prioriti
pathogen
categori
c
nation
institut
allergi
infecti
diseas
center
diseas
control
prevent
potenti
caus
signific
morbid
mortal
human
major
econom
public
health
impact
review
pteropid
bat
famili
pteropodida
commonli
known
fli
fox
predomin
natur
reservoir
hev
niv
review
although
evid
henipaviru
infect
report
wider
rang
frugivor
insectivor
bat
sinc
initi
recognit
virus
repeatedli
reemerg
total
hev
outbreak
occur
australia
alway
involv
hors
intermedi
host
human
infect
includ
four
fatal
recent
septemb
review
niv
also
repeatedli
caus
spillov
event
involv
hundr
human
case
sinc
least
nine
recogn
occurr
primarili
bangladesh
india
sinc
review
recent
march
sever
recent
niv
outbreak
higher
rate
acut
respiratori
distress
syndrom
conjunct
enceph
epidemiolog
find
consist
multipl
round
persontoperson
transmiss
higher
case
fatal
rate
direct
transmiss
viru
fli
fox
human
via
contamin
food
demonstr
addit
highli
pathogen
natur
henipavirus
also
distinguish
paramyxovirus
unusu
broad
host
tropism
host
cell
infect
niv
hev
requir
two
membraneanchor
envelop
glycoprotein
attach
g
glycoprotein
bind
viral
receptor
fusion
f
glycoprotein
drive
virushost
cell
membran
merger
henipaviru
g
glycoprotein
lack
hemagglutinin
neuraminidas
activ
f
glycoprotein
typic
class
fusion
glycoprotein
review
host
cell
membran
anchor
protein
ligand
shown
receptor
employ
henipavirus
present
licens
therapeut
avail
treat
infect
caus
henipavirus
recent
isol
extens
character
neutral
human
monoclon
antibodi
hmab
recogn
receptor
bind
domain
hev
niv
g
glycoprotein
hmab
potent
neutral
virus
vitro
maintain
biolog
activ
vivo
suggest
possibl
util
passiv
therapeut
modal
follow
henipaviru
infect
report
develop
character
novel
ferret
model
acut
niv
infect
associ
diseas
well
conduct
first
henipaviru
therapeut
antibodi
trial
use
hmab
togeth
data
demonstr
nivmedi
diseas
ferret
close
resembl
seen
human
presenc
respiratori
neurolog
diseas
demonstr
effect
postexposur
therapeut
repres
first
antivir
drug
candid
show
vivo
efficaci
treat
lethal
nivmedi
diseas
first
human
mab
therapeut
develop
test
treatment
henipaviru
infect
human
diseas
result
niv
infect
vari
intens
acut
febril
ill
one
progress
sever
central
nervou
respiratori
diseas
patholog
find
show
system
vascul
necrot
alveol
meningoenceph
diseas
experiment
infect
cat
hamster
similar
hamster
meninoenceph
promin
cat
develop
acut
respiratori
diseas
sought
assess
new
ferret
model
niv
pathogenesi
preliminari
observ
confirm
suscept
niv
infect
develop
system
vascul
involv
central
nervou
respiratori
system
ferret
emerg
model
sever
viral
respiratori
diseas
includ
avian
influenza
sever
acut
respiratori
syndrom
morbillivirus
close
rel
henipavirus
offer
combin
advantag
either
aforement
laboratori
anim
speci
rel
small
mammal
display
complex
behavior
especi
relat
handler
may
use
advantag
clinic
assess
howev
also
suffici
larg
enabl
repeat
collect
wide
rang
clinic
sampl
throughout
cours
experiment
infect
well
administr
potenti
therapi
manner
similar
consist
human
medicin
initi
niv
minim
infecti
dose
studi
purpos
determin
appropri
challeng
dose
subsequ
work
would
reliabl
product
infect
ferret
dose
administ
group
two
ferret
oralnas
like
rout
natur
infect
base
prior
experi
niv
infect
cat
use
similar
paramet
defin
infect
endpoint
ferret
purpos
human
euthanasia
use
surrog
lethal
endpoint
fever
plu
sign
rapidli
progress
clinic
ill
includ
gener
eg
inappet
depress
local
egdyspnea
neurolog
sign
diseas
sign
ferret
receiv
one
anim
receiv
remain
well
throughout
period
observ
shed
detect
viru
viral
rna
seroconvert
tissu
normal
post
mortem
histolog
examin
remain
ferret
develop
fever
day
postinfect
dpi
rapidli
progress
clinic
ill
dpi
ferret
inocul
euthan
dpi
respect
inocul
euthan
dpi
respect
one
ferret
inocul
euthan
dpi
clinic
sign
affect
ferret
includ
sever
depress
cough
serou
nasal
discharg
dyspnea
subcutan
edema
head
sever
depress
orthopnea
expiratori
dyspnea
sever
depress
orthopnea
cutan
ecchymos
sever
depress
vomit
hypothermia
obtund
tremor
hind
limb
paresi
gross
patholog
find
compris
vari
degre
subcutan
hemorrhag
edema
head
neck
center
upon
local
lymph
node
diseas
ferret
focal
rais
pinhead
hemorrhag
nodul
scatter
throughout
pulmonari
parenchyma
scatter
intraabdomin
petechi
hemorrhag
histopatholog
diseas
ferret
reveal
acut
focal
necrot
alveol
pulmonari
vascul
acut
glomerular
necrosi
focal
necrosi
spleen
sever
diffus
subacut
inflamm
organ
connect
tissu
head
neck
less
commonli
mild
focal
nonsuppur
mening
focal
cystiti
sever
acut
necrot
salping
acut
focal
coagul
necrosi
adren
cortex
sever
acut
thyroid
two
ferret
demonstr
neurolog
sign
nonsuppur
mening
syncytia
usual
present
lesion
often
contain
abund
viral
antigen
figur
mildli
affect
lymph
node
focal
mononuclear
cell
neutrophil
inflamm
capsul
accompani
zone
subcapsular
lymphocyt
deplet
sever
affect
lymph
node
sever
extens
hemorrhag
coagul
necrosi
often
result
destruct
entir
node
antigen
stain
mainli
syncytia
live
margin
necrot
focu
figur
clinic
healthi
ferret
gross
patholog
chang
viral
antigen
signific
histolog
lesion
found
tissu
examin
viru
dissemin
tissu
tropism
niv
n
gene
rna
measur
pharyng
rectal
swab
blood
sampl
cours
infect
varieti
tissu
recov
necropsi
among
ferret
develop
clinic
diseas
niv
rna
detect
blood
figur
time
euthanasia
two
also
sampl
collect
two
day
earlier
one
ferret
remain
healthi
period
observ
demonstr
low
level
viral
rna
blood
dpi
interestingli
ferret
share
cage
ferret
viral
rna
recov
pharyng
rectal
swab
dpi
suggest
viral
shed
viral
rna
albeit
low
level
detect
pharyng
swab
ferret
demonstr
clinic
diseas
figur
rectal
swab
two
figur
notabl
niv
rna
detect
tissu
clinic
healthi
ferret
anim
clinic
sign
signific
level
viral
rna
detect
adren
kidney
lung
bronchial
lymph
node
spleen
tissu
figur
although
lower
rel
level
niv
rna
also
detect
bladder
liver
ovari
test
uterin
horn
brain
figur
infect
ferret
niv
rna
olfactori
lobe
brain
ferret
show
tremor
hind
limb
weak
highest
level
occipit
lobe
although
realtim
pcr
help
discern
viru
distribut
infect
anim
discrimin
infecti
noninfecti
genet
materi
reason
viru
isol
attempt
sampl
tissu
niv
rna
rel
express
level
niv
recov
almost
tissu
high
level
niv
rna
figur
top
panel
indic
individu
data
bar
lung
lymphoid
tissu
site
extens
viru
replic
viru
also
isol
tissu
lower
niv
rna
level
includ
occipit
lobe
uterin
horn
ovari
ferret
olfactori
lobe
ferret
figur
bottom
panel
ferret
niv
isol
brain
histolog
lesion
includ
nonsuppur
mening
recent
describ
hmab
engag
receptorbind
site
viral
attach
g
glycoprotein
potent
neutral
hev
niv
vitro
retain
biolog
activ
vivo
evalu
efficaci
ferret
model
two
time
point
select
hr
pre
hr
post
niv
challeng
treatment
group
contain
three
ferret
except
control
group
n
indic
time
mg
administ
via
intraven
cathet
one
ferret
postchalleng
group
given
intraperiton
due
difficulti
venou
catheter
control
ferret
given
pb
ferret
challeng
oralnas
dose
niv
tenfold
determin
doserang
studi
dpi
ferret
febril
control
anim
start
demonstr
sign
clinic
ill
similar
seen
initi
studi
dpi
control
sever
depress
subcutan
edema
head
cutan
hemorrhag
euthan
dpi
ferret
postgroup
also
febril
variabl
level
depress
suppress
play
activ
notabl
sign
abnorm
ferret
behavior
dpi
temperatur
start
fall
demonstr
moder
mild
edema
throat
remain
febril
local
sign
dpi
ferret
depress
inappet
cutan
ecchymos
ferret
mark
hind
limb
paresi
gener
tremor
anim
euthan
ferret
three
post
one
pregroup
well
free
diseas
sign
remain
end
studi
tabl
upon
studi
complet
dpi
surviv
anim
euthan
control
two
ferret
prechalleng
group
succumb
infect
gross
microscop
patholog
reveal
find
similar
describ
studi
howev
ferret
frequenc
pinpoint
hemorrhag
lesion
observ
pulmonari
parenchyma
reduc
lesion
much
smaller
suggest
diseas
progress
respiratori
tract
dampen
figur
consist
surviv
dpi
histopatholog
find
control
two
diseas
prechalleng
group
ferret
similar
describ
studi
howev
ferret
niv
antigen
present
ependym
tissu
figur
ferret
niv
antigen
present
within
neuron
neuropil
cerebellum
figur
support
suggest
ferret
could
appropri
model
nivmedi
meningoencephalit
diseas
signific
patholog
abnorm
found
surviv
ferret
blood
swab
tissu
test
presenc
niv
rna
result
shown
figur
ferret
anim
surviv
prechalleng
group
detect
level
viral
rna
blood
dpi
figur
wherea
sampl
neg
ferret
signific
viremia
dpi
highest
level
niv
rna
control
dpi
viral
rna
level
ferret
similar
found
control
wherea
niv
rna
level
decreas
ferret
undetect
postchalleng
group
ferret
viral
rna
level
oral
swab
highest
among
control
prechalleng
group
howev
postchalleng
group
ferret
shed
viru
cours
infect
figur
niv
rna
level
rectal
swab
low
except
figur
togeth
data
demonstr
treat
ferret
except
signific
amount
system
mucos
niv
least
dpi
control
two
diseas
pregroup
ferret
similar
high
level
viral
rna
tissu
figur
convers
postchalleng
group
ferret
significantli
reduc
level
viral
rna
figur
viru
isol
attempt
sampl
detect
niv
rna
figur
day
postinfect
niv
isol
blood
one
control
anim
pharyng
swab
control
anim
rectal
swab
ferret
blood
swab
sampl
neg
viru
isol
despit
high
level
viral
rna
detect
viru
isol
major
control
anim
tissu
two
diseas
pregroup
ferret
tissu
wherea
postgroup
ferret
tissu
neg
niv
togeth
data
demonstr
treatment
reduc
viral
replic
spread
provid
signific
therapeut
benefit
lead
surviv
infect
anim
postchalleng
group
evalu
whether
correl
concentr
protect
exist
level
serum
measur
figur
coincid
ferret
highest
level
serum
prechalleng
along
longestlast
serum
level
figur
anim
group
surviv
dpi
prechalleng
group
ferret
significantli
lower
concentr
compar
postchalleng
group
figur
importantli
concentr
day
correl
surviv
may
indic
exist
critic
therapeut
window
follow
viru
exposur
dpi
level
anim
drop
lowest
among
postchalleng
group
interestingli
dpi
higher
serum
level
postgroup
succumb
diseas
dpi
wherea
low
level
day
surviv
infect
antibodi
specif
niv
g
measur
serum
postchalleng
nivg
specif
antibodi
detect
control
dpi
figur
ferret
high
level
gspecif
antibodi
dpi
like
reflect
ferret
niv
gspecif
antibodi
low
dpi
higher
amount
antibodi
present
postchalleng
group
dpi
nivg
specif
antibodi
respons
increas
ferret
highest
level
found
ferret
present
studi
describ
potent
neutral
human
monoclon
antibodi
mechan
action
involv
bind
singl
epitop
within
receptor
bind
domain
henipaviru
g
glycoprotein
affect
block
receptor
engag
viru
infect
hev
niv
caus
acut
often
fatal
diseas
anim
human
although
viru
neutral
escap
mutant
unlik
day
evalu
whether
resist
viru
present
ferret
viru
isol
repeat
tissu
homogen
presenc
absenc
viru
isol
sampl
absenc
howev
viru
isol
tissu
present
data
shown
togeth
data
demonstr
viru
circul
ferret
time
euthanasia
still
highli
sensit
evid
escap
mutant
found
addit
also
examin
neutral
activ
differ
isol
niv
hev
includ
nivmalaysia
nivbangladesh
hevredland
importantli
neutral
virus
potent
hevredland
complet
neutral
isol
even
sensit
complet
neutral
occur
data
support
potenti
broad
applic
postexposur
therapeut
option
henipavirusinfect
individu
new
ferret
model
niv
infect
pathogenesi
develop
present
studi
unlik
cat
hamster
model
ferret
model
uniqu
exhibit
sever
respiratori
neurolog
diseas
gener
vascul
nivmedi
diseas
human
describ
system
endotheli
infect
accompani
vascul
thrombosi
ischaemia
necrosi
histopatholog
chang
infect
individu
especi
note
central
nervou
system
cn
widespread
presenc
viral
antigen
neuron
parenchym
cell
necrot
foci
cn
also
endotheli
cell
affect
blood
vessel
vascul
endotheli
infect
also
seen
organ
examin
ferret
clinic
diseas
includ
vascular
fibrinoid
necrosi
multipl
organ
necrot
alveol
syncytia
endothelium
alveolar
epithelium
necrot
lymphaden
histopatholog
lesion
includ
sever
focal
necrot
alveol
vascul
degener
glomerular
tuft
focal
necrosi
widerang
tissu
signific
quantiti
viral
antigen
blood
vessel
wall
syncyti
cell
frequent
present
viral
antigen
present
neuron
infecti
niv
isol
multipl
organ
includ
brain
sever
anim
also
demonstr
signific
neurolog
diseas
widespread
presenc
niv
antigen
neuron
parenchym
cell
cn
extens
nivinfect
ferret
compar
infect
human
could
relat
length
diseas
cours
experiment
versu
natur
infect
specul
widespread
infect
cn
would
develop
anim
allow
succumb
diseas
without
euthanasia
overal
nivmedi
diseas
ferret
hallmark
nivinfect
human
repres
novel
relev
anim
model
recent
vaccin
studi
demonstr
henipaviru
gspecif
antibodi
critic
protect
diseas
evid
passiv
protect
niv
recent
hev
challeng
use
hamster
polyclon
antiserum
murin
mab
reactiv
niv
glycoprotein
provid
hamster
howev
prior
studi
challeng
viru
antibodi
administ
intraperiton
inject
either
simultan
immedi
follow
challeng
examin
neutral
fullyhuman
mab
potenti
human
use
consist
suscept
anim
model
challeng
drug
deliveri
mimick
potenti
reallif
scenario
hmab
ideal
therapeut
target
critic
function
domain
g
glycoprotein
fulli
human
igg
achiev
full
protect
nivmedi
diseas
ferret
receiv
singl
infus
antibodi
hr
postchalleng
protect
one
anim
treat
prior
challeng
ferret
survivor
pregroup
highest
prechalleng
level
best
antibodi
longev
uniqu
fever
clinic
sign
viru
detect
time
anim
except
extrem
low
level
viremia
dpi
find
suggest
combin
initi
high
level
antibodi
subsequ
longev
may
provid
protect
remain
ferret
higher
level
day
postchalleng
correl
protect
diseas
wherea
level
thereaft
potenti
highlight
first
day
follow
infect
import
therapeut
window
day
lower
concentr
pregroup
may
suffici
neutral
viru
allow
initi
infect
postgroup
higher
concentr
dpi
may
suffici
neutral
enough
viru
andor
prevent
widespread
dissemin
viru
provid
window
anim
mount
effect
immun
respons
postchalleng
group
host
immun
system
may
opportun
hr
initi
primari
respons
antibodymedi
deplet
viru
prechalleng
group
antibodyviru
complex
like
form
almost
immedi
follow
challeng
primari
innat
respons
may
dampen
level
decreas
time
viru
replic
initi
postchalleng
group
may
potent
secondari
respons
allow
surviv
inde
anim
prechalleng
group
develop
sever
diseas
day
level
decreas
timelin
similar
diseas
progress
naiv
anim
whether
primari
secondari
antibodi
respons
postchalleng
group
appear
earlier
dpi
robust
surviv
ferret
postchalleng
group
repres
major
step
forward
toward
viabl
passiv
antivir
therapeut
treat
henipaviru
infect
sinc
target
receptorbind
domain
g
conformationdepend
antibodi
believ
maintain
efficaci
vivo
cours
applic
infect
host
given
acut
natur
henipaviru
infect
receptor
specif
mutat
escap
sensit
seem
unlik
mutat
gener
neutral
escap
variant
virus
would
like
also
acquir
defect
receptor
bind
fit
data
support
notion
escap
mutant
found
treat
anim
succumb
diseas
examin
confirm
potent
crossreact
neutral
activ
nivmalaysia
origin
recent
hevredland
nivbangladesh
isol
examin
effect
treat
anim
expos
henipaviru
isol
import
futur
studi
also
critic
increas
number
anim
studi
explor
therapeut
window
postchalleng
although
hr
relev
known
exposur
laboratori
accid
import
defin
limit
therapeut
window
data
repres
first
human
antibodi
therapi
success
evalu
vivo
prevent
lethal
henipaviru
infect
strongli
suggest
may
prove
use
therapeut
use
treat
diseas
peopl
caus
import
emerg
pathogen
eight
adult
year
old
ferret
use
niv
minim
infecti
dose
studi
eight
adult
ferret
use
vivo
efficaci
studi
anim
studi
endors
csiro
aahl
anim
ethic
committe
ferret
hous
pair
cage
room
fed
twice
daili
complet
premium
dri
food
provid
water
ad
lib
implant
temperatur
transpond
niv
challeng
administr
specimen
collect
ferret
anaesthetis
intramuscular
inject
ketamin
ketamil
troy
laboratori
new
south
wale
nsw
au
medetomidin
domitor
pfizer
anim
health
nsw
au
dose
rate
approxim
mgkg
mgkg
respect
anesthet
revers
atimepazol
antisedan
novarti
pendl
hill
nsw
au
given
intramuscularli
dose
medetomidin
follow
challeng
ferret
assess
daili
score
rang
clinic
observ
includ
alert
play
curios
depress
food
consumpt
fece
product
respir
rate
realtim
monitor
bodi
temperatur
anim
done
use
transpond
implant
subcutan
rectal
temperatur
bodi
weight
record
sampl
day
ferret
clinic
assess
exhibit
sign
sever
diseas
natur
recoveri
consid
unlik
anim
euthan
intraven
inject
sodium
pentabarbiton
ferret
inocul
oronas
low
passag
niv
isol
nivmalaysia
eukk
stock
viru
titer
studi
niv
dose
ferret
per
dose
base
outcom
studi
efficaci
studi
ferret
challeng
hmab
prepar
previous
describ
ferret
anaesthetis
intraven
cathet
place
left
jugular
vein
administ
via
cathet
slow
infus
minut
ferret
mg
per
ferret
ferret
receiv
antibodi
hour
niv
challeng
ferret
receiv
antibodi
hour
challeng
two
ferret
receiv
pb
one
hour
challeng
hour
challeng
cathet
withdrawn
anim
allow
recov
anaesthesia
blood
oral
swab
rectal
swab
collect
day
postinfect
dpi
purpos
assist
establish
infect
statu
anim
studi
addit
sampl
collect
incub
period
dpi
two
aliquot
whole
blood
remov
sampl
serum
collect
aliquot
one
aliquot
whole
blood
ad
ribopur
lysi
buffer
ambion
inc
austin
tx
usa
contain
sodium
acet
duplic
swab
place
avl
viral
lysi
buffer
qiagen
pti
ltd
clifton
hill
victoria
au
pb
euthanasia
tissu
sampl
collect
asept
lung
apic
diaphragmat
lobe
brain
olfactori
occipit
lobe
heart
bronchial
lymph
node
spleen
liver
kidney
bladder
adren
gland
femal
uterin
horn
ovari
collect
male
test
collect
tissu
either
fix
neutral
buffer
formalin
submerg
rlt
lysi
buffer
qiagen
pti
ltd
contain
mm
stainless
steel
bead
biospec
product
inc
bartlesvil
ok
usa
submerg
pb
contain
mm
stainless
steel
bead
studi
specimen
place
efficaci
studi
blood
swab
tissu
sampl
process
immedi
rna
extract
duplic
sampl
pb
store
viru
isol
rna
purifi
blood
cell
use
ribopureblood
kit
ambion
inc
swab
use
qiaamp
viral
rna
kit
qiagen
pti
ltd
tissu
use
rneasi
mini
kit
qiagen
pti
ltd
prior
process
tissu
homogen
cycl
sec
use
minibead
beater
biospec
product
inc
centrifug
pellet
debri
taqman
pcr
assay
preform
previous
describ
sampl
amplifi
geneamp
sequenc
detect
system
appli
biosystem
foster
citi
ca
ct
valu
repres
niv
nucleocapsid
n
gene
express
analyz
data
record
rel
niv
n
gene
express
level
viru
isol
perform
previous
describ
attempt
specimen
posit
niv
rna
tissu
process
routin
histolog
method
section
tissu
stain
hematoxylin
eosin
examin
histopatholog
chang
separ
section
stain
immunohistochem
techniqu
previous
describ
use
rabbit
polyclon
antiserum
niv
nucleoprotein
multiplex
microspher
assay
perform
previous
describ
machin
miraibio
softwar
miraibio
group
south
san
francisco
ca
util
assay
master
plex
ct
data
acquisit
masterplex
qt
v
data
analysi
sampl
assay
simultan
concentr
extrapol
standard
curv
use
nonlinear
regress
analysi
graphpad
softwar
san
diego
ca
